All patients with inflammatory bowel disease should have bone density assessment: pro

Inflamm Bowel Dis. 2001 May;7(2):158-62; discussion 168-9. doi: 10.1097/00054725-200105000-00012.

Abstract

Bone loss is a common problem for individuals with inflammatory bowel disease. Corticosteroids play an important role in the development of osteoporosis in these patients; however, active disease and longer disease duration also appear to increase the risk of osteoporosis. Given the current burden of osteoporosis, bone mineral density is recommended.

MeSH terms

  • Adolescent
  • Adrenal Cortex Hormones / adverse effects
  • Adult
  • Bone Density*
  • Child
  • Controlled Clinical Trials as Topic
  • Cross-Sectional Studies
  • Female
  • Humans
  • Inflammatory Bowel Diseases / complications
  • Inflammatory Bowel Diseases / physiopathology*
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Osteoporosis / complications
  • Osteoporosis / physiopathology*

Substances

  • Adrenal Cortex Hormones